Kaplan and HerMD Founder Dr. Somi Javaid Hold Webinar to Spotlight Menopause and Critical Issues in Women’s Midlife Health

Key Terms

menopause medical

Menopause is the natural stage in a person’s life when menstrual periods stop permanently because the ovaries reduce production of hormones like estrogen and progesterone; it is typically diagnosed after 12 consecutive months without a period. Investors care because menopause drives demand for medical treatments, diagnostic services, over‑the‑counter products and workplace accommodations, similar to a market shift when a large customer group changes its needs, affecting revenue and product strategies across health, consumer and employer sectors.

ob/gyn medical

An ob/gyn is a physician who specializes in pregnancy, childbirth and women’s reproductive health, combining obstetrics (care during pregnancy and delivery) and gynecology (care of the reproductive system). Investors pay attention because ob/gyn demand drives revenue for hospitals, clinics, medical device makers and drugmakers tied to maternity and women’s health—think of them as a primary customer group whose changing numbers, regulations or treatment trends can shift sales like weather affects a farmer’s harvest.

hormone therapy medical

Hormone therapy is a medical treatment that adds, blocks, or adjusts natural chemical messengers in the body to correct imbalances or influence growth, functioning, or symptoms; think of it like adjusting a thermostat to bring a room to the right temperature. It matters to investors because trial results, approvals, safety concerns, or broader demand can change revenue prospects for drug makers, suppliers, and insurers, affecting stock value and risk.

FORT LAUDERDALE, Fla.--(BUSINESS WIRE)-- Global education provider Kaplan will host a free webinar on January 27 at 1 PM ET with Dr. Somi Javaid, board-certified OB/GYN, surgeon, and founder of women’s health innovator HerMD. The event, “Menopause Matters: The Case for Better Menopause Care to Improve Women’s Midlife Health,” will focus on closing critical gaps in menopause education and highlight why better menopause care is essential for women’s health.

The webinar will underscore the urgent need for stronger provider education on menopause. In one study, 93% of medical residents say they strongly agree that residents nationwide should have access to a standardized menopause curriculum that could be utilized in their programs, but only 31% of OB/GYN residency programs offer dedicated menopause training. The consequences are far-reaching:

• Health Risks: Menopause symptoms can accelerate long-term risks to bone, brain, and heart health—with up to 20% of bone loss occurring during the transition.
• Economic Impact: Unaddressed symptoms lead to steep productivity losses, costing the U.S. $1.8 billion annually—and $26.6 billion when medical expenses are included.
• Treatment Gap: Despite decades of evidence supporting hormone therapy’s safety and effectiveness, usage has plunged to historic lows, with fewer than 4% of women ages 50–59 using it in 2023.

Dr. Somi Javaid said:

“It is time to recognize that menopause can have serious consequences if left undiagnosed and untreated. Providers must be equipped with evidence-based education to guide women toward personalized treatment pathways grounded in today’s data, not yesterday’s myths. The future of medicine demands prevention, not pursuit, of disease. Ignoring menopause education is no longer an option—the consequences are too great.”

The event is supported by in-kind sponsor dotted…, which is committed to supporting evidence-based menopause education and forging strategic relationships across the healthcare industry to advance care for women at midlife and beyond.

According to an Ipsos poll conducted on behalf of Kaplan, nearly half of all medical school students report they used a Kaplan product or service during their academic career.

For more information and to register for the free event, visit the event page.

About Kaplan

Kaplan, Inc. is a global educational services company that helps individuals and institutions advance their goals in an ever-changing world. Our broad portfolio of solutions help students and professionals further their education and careers, universities and educational institutions attract and support students, and businesses maximize employee recruitment, retention, and development. Stanley Kaplan founded our company in 1938 with a mission to expand educational opportunities for students of all backgrounds. Today, our thousands of employees working in 27 countries/regions continue Stanley’s mission as they serve about 1.2 million students and professionals, 15,000 corporate clients, and 3,300 schools, school districts, colleges, and universities worldwide. Kaplan is a subsidiary of the Graham Holdings Company (NYSE: GHC). Learn more at kaplan.com.

About HerMD

HerMD is a healthcare company redefining how women access and experience care, particularly in the often-overlooked areas of menopause and sexual health. By addressing critical gaps in provider education and access, HerMD continues to lead the national conversation around what women's healthcare can—and should—be. Learn more at hermd.com.

Note to editors: Kaplan is a subsidiary of Graham Holdings Company (NYSE: GHC)

View source version on businesswire.com: https://www.businesswire.com/news/home/20260113435065/en/

Press Contact: Russell Schaffer, russell.schaffer@kaplan.com

Source: Kaplan